To test our hypothesis that the myosin DRX to SRX ratio may be altered in individuals with type 2 diabetes, we performed loaded Mant-ATP chase assays on isolated and permeabilised single muscle fibres (Fig. 1a). The gene discussed is SRXN1; the disease is type 2 diabetes mellitus.